Alpha Teknova (NASDAQ:TKNO - Get Free Report) was downgraded by equities researchers at Roth Capital from a "strong-buy" rating to a "hold" rating in a report released on Friday, Zacks reports.
TKNO has been the topic of several other reports. BTIG Research raised Alpha Teknova from a "neutral" rating to a "buy" rating and set a $8.00 target price on the stock in a report on Tuesday, August 11th. Zacks Research raised Alpha Teknova to a "hold" rating in a research note on Thursday, August 6th. Wall Street Zen upgraded Alpha Teknova from a "hold" rating to a "buy" rating in a report on Saturday, August 8th. Jefferies Financial Group began coverage on Alpha Teknova in a report on Thursday, September 17th. They set a "buy" rating and a $9.00 price target for the company. Finally, Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Alpha Teknova in a research note on Wednesday, November 4th. Three equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $8.75.
Get Our Latest Stock Report on TKNO
Alpha Teknova Price Performance
TKNO stock opened at $7.63 on Friday. Alpha Teknova has a one year low of $1.91 and a one year high of $9.48. The company's fifty day moving average price is $7.94 and its 200-day moving average price is $5.24. The company has a debt-to-equity ratio of 0.22, a quick ratio of 2.72 and a current ratio of 3.56. The company has a market capitalization of $479.93 million, a PE ratio of -26.31 and a beta of 0.96.
Alpha Teknova (NASDAQ:TKNO - Get Free Report) last posted its earnings results on Wednesday, November 4th. The company reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.01. The company had revenue of $12.70 million during the quarter, compared to analysts' expectations of $11.71 million. Alpha Teknova had a negative net margin of 34.76% and a negative return on equity of 24.95%. On average, equities analysts anticipate that Alpha Teknova will post -0.27 EPS for the current fiscal year.
Institutional Investors Weigh In On Alpha Teknova
Several large investors have recently added to or reduced their stakes in the stock. Deutsche Bank AG purchased a new stake in Alpha Teknova during the second quarter valued at approximately $62,000. Ieq Capital LLC bought a new stake in shares of Alpha Teknova in the 2nd quarter valued at approximately $62,000. Susquehanna International Group LLP purchased a new position in shares of Alpha Teknova in the 2nd quarter worth approximately $115,000. Fielder Capital Group LLC purchased a new position in shares of Alpha Teknova in the 2nd quarter worth approximately $143,000. Finally, Marshall Wace LLP purchased a new position in shares of Alpha Teknova in the 3rd quarter worth approximately $330,000. 13.81% of the stock is owned by institutional investors.
About Alpha Teknova
(
Get Free Report)
Alpha Teknova, Inc. develops and manufactures reagents used in life science research and the development and production of biopharmaceuticals and diagnostic products. Its offerings include cell culture media, buffers, molecular biology reagents, proteins and other laboratory materials. The company provides both catalog products and custom reagent development and manufacturing services. Its customers include biotechnology and pharmaceutical companies, diagnostic developers, academic institutions and research laboratories.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Alpha Teknova, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alpha Teknova wasn't on the list.
While Alpha Teknova currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.